Elevated number of cells secreting transforming growth factor β in Guillain-Barré syndrome

APMIS

Volumn 111, Issue 12, 2003, Pages 1095-1104

  Dahle, C ^a   Kvarnstrom M ^a   Ekerfelt, C ^a   Samuelsson, M ^b   Ernerudh, J ^a  

^a LINKÖPING UNIVERSITY HOSPITAL   (Sweden)

^b ÖREBRO UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Cytokines; ELISPOT; Guillain Barr ; IL 4; Syndrome; TGF

Indexed keywords

GAMMA INTERFERON; INTERLEUKIN 4; INTERLEUKIN 6; TRANSFORMING GROWTH FACTOR BETA; TUMOR NECROSIS FACTOR ALPHA;

ADULT; AGED; ARTICLE; CELL COUNT; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; DISEASE COURSE; ENZYME LINKED IMMUNOSORBENT ASSAY; ENZYME LINKED IMMUNOSPOT ASSAY; FEMALE; GUILLAIN BARRE SYNDROME; HUMAN; HUMAN CELL; MALE; MONONUCLEAR CELL; PRIORITY JOURNAL;

ADOLESCENT; ADULT; AGED; FEMALE; GUILLAIN-BARRE SYNDROME; HUMANS; INTERFERON TYPE II; INTERLEUKIN-4; INTERLEUKIN-6; LEUKOCYTES, MONONUCLEAR; LYMPHOCYTE COUNT; MALE; MIDDLE AGED; TRANSFORMING GROWTH FACTOR BETA; TUMOR NECROSIS FACTOR-ALPHA;

EID: 0346494935     PISSN: 09034641     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1600-0463.2003.apm1111204.x     Document Type: Article

References (51)

1. Hartung HP, Pollard JD, Harvey GK, Toyka KV. Immunopathogenesis and treatment of the Guillain-Barre syndrome-Part I. Muscle Nerve 1995; 18:137-53.
2. Hartung HP, Pollard JD, Harvey GK, Toyka KV. Immunopathogenesis and treatment of the Guillain-Barre syndrome-Part II. Muscle Nerve 1995;18:154-64.
3. Shoenfeld Y, George J, Peter JB. Guillain-Barre as an autoimmune disease. Int Arch Allergy Immunol 1996;109:318-26.
4. Bansil S, Mithen FA, Cook SD, Sheffet A, Rohowsky-Kochan C. Clinical correlation with serum-soluble interleukin-2 receptor levels in Guillain-Barre syndrome. Neurology 1991;41:1302-5.
5. Hartung HP, Hughes RA, Taylor WA, Heininger K, Reiners K, Toyka KV. T cell activation in Guillain-Barre syndrome and in MS: elevated serum levels of soluble IL-2 receptors. Neurology 1990; 40:215-8.
6. Hartung HP, Reiners K, Schmidt B, Stoll G, Toyka KV Serum interleukin-2 concentrations in Guillain-Barre syndrome and chronic idiopathic demyelinating polyradiculoneuropathy: comparison with other neurological diseases of presumed immunopathogenesis. Ann Neurol 1991;30:48-53.
7. Taylor WA, Hughes RA. T lymphocyte activation antigens in Guillain-Barre syndrome and chronic idiopathic demyelinating polyradiculoneuropathy. J Neuroimmunol 1989;24:33-9.
8. Dahle C, Vrethem M, Ernerudh J. T lymphocyte subset abnormalities in peripheral blood from patients with the Guillain-Barre syndrome. J Neuroimmunol 1994;53:219-25.
9. Romagnani S. T-cell subsets (Th1 versus Th2). Ann Allergy Asthma Immunol 2000;85:9-18; quiz 18, 21.
10. Liblau RS, Singer SM, McDevitt HO. Th1 and Th2 CD4+ T cells in the pathogenesis of organ-specific autoimmune diseases. Immunol Today 1995;16:34-8.
11. Lafaille JJ. The role of helper T cell subsets in autoimmune diseases. Cytokine Growth Factor Rev 1998;9:139-51.
12. Simon AK, Seipelt E, Sieper J. Divergent T-cell cytokine patterns in inflammatory arthritis. Proc Natl Acad Sci U S A 1994;91:8562-6.
13. Zhu J, Link H, Mix E, Olsson T, Huang WX. Th1-like cell responses to peripheral nerve myelin components over the course of experimental allergic neuritis in Lewis rats. Acta Neurol Scand 1994;90:19-25.
14. Zhu J, Mix E, Olsson T, Link H. Cellular mRNA expression of interferon-gamma, IL-4 and transforming growth factor-beta (TGF-beta) by rat mononuclear cells stimulated with peripheral nerve myelin antigens in experimental allergic neuritis. Clin Exp Immunol 1994;98:306-12.
15. Zhu J, Mix E, Issazadeh S, Link H. Dynamics of mRNA expression of interferon-interleukin-4 and transforming growth factor in sciatic nerve and lymphoid organs in experimental allergic neuritis. Eur J Neurol 1996;3:232-40.
16. Ekerfelt C, Dahle C, Weissert R, Kvarnström M, Olsson T, Ernerudh J. Transfer of myelin-specific cells deviated in vitro towards IL-4 production ameliorates ongoing experimental allergic neuritis. Clin Exp Immunol 2001;123:112-8.
17. Dahle C, Ekerfelt C, Vrethem M, Samuelsson M, Ernerudh J. T helper type 2 like cytokine responses to peptides from P0 and P2 myelin proteins during the recovery phase of Guillain-Barre syndrome. J Neurol Sci 1997;153:54-60.
18. Bach JE Non-Th2 regulatory T-cell control of Th1 autoimmunity. Scand J Immunol 2001;54: 21-9.
19. Prud'homme GJ, Piccirillo CA. The inhibitory effects of transforming growth factor-beta-1 (TGF-beta1) in autoimmune diseases. J Autoimmun 2000;14:23-42.
20. Jooss K, Gjata B, Danos O, von Boehmer H, Sarukhan A. Regulatory function of in vivo anergized CD4(+) T cells. Proc Natl Acad Sci U S A 2001;98:8738-43.
21. Maimone D, Annunziata P, Simone IL, Livrea P, Guazzi GC. Interleukin-6 levels in the cerebrospinal fluid and serum of patients with Guillain-Barre syndrome and chronic inflammatory demyelinating polyradiculoneuropathy. J Neuroimmunol 1993;47:55-61.
22. Sharief MK, McLean B, Thompson EJ. Elevated serum levels of tumor necrosis factor-alpha in Guillain-Barre syndrome. Ann Neurol 1993;33: 591-6.
23. Exley AR, Smith N, Winer JB. Tumour necrosis factor-alpha and other cytokines in Guillain-Barre syndrome. J Neurol Neurosurg Psychiatry 1994;57:1118-20.
24. Sindern E, Schweppe K, Ossege LM, Malin JP Potential role of transforming growth factor-beta 1 in terminating the immune response in patients with Guillain-Barre syndrome. J Neurol 1996; 243:264-8.
25. Hohnoki K, Inoue A, Koh CS. Elevated serum levels of IFN-gamma, IL-4 and TNF-alpha/unelevated serum levels of IL-10 in patients with demyelinating diseases during the acute stage. J Neuroimmunol 1998;87:27-32.
26. Sharief MK, Ingram DA, Swash M, Thompson EJ. I.v. immunoglobulin reduces circulating proinflammatory cytokines in Guillain-Barre syndrome. Neurology 1999;52:1833-8.
27. Press R, Deretzi G, Zou LP, Zhu J, Fredman P, Lycke J, et al. IL-10 and IFN-gamma in Guillain-Barre syndrome. Network Members of the Swedish Epidemiological Study Group. J Neuroimmunol 2001;112:129-38.
28. Asbury AK, Arnason BGW, Karp HR, McFarlin DE. Criteria for diagnosis of Guillain-Barré syndrome. Ann Neurol 1978;3:565-6.
29. Miller-Fisher C. An unusual variant of acute idiopathic polyneuritis (syndrome of ophtalmoplegia, ataxia and areflexia). N Engl J Med 1956;255:57-65.
30. Osterman PO, Fagius J, Lundemo G, Pihlstedt P, Pirskanen R, Sidén Å, et al. Beneficial effects of plasma exchange in acute inflammatory polyradiculoneuropathy. Lancet 1984;2:1296-9.
31. Bøyum A. Isolation of mononuclear cells and granulocytes from human blood. Isolation of monuclear cells by one centrifugation, and of granulocytes by combining centrifugation and sedimentation at 1 g. Scand J Clin Lab Invest Suppl 1968;97:77-89.
32. Khalili-Shirazi A, Hughes RA, Brostoff SW, Linington C, Gregson N. T cell responses to myelin proteins in Guillain-Barre syndrome. J Neurol Sci 1992;111:200-3.
33. Olee T, Powers JM, Brostoff SW A T cell epitope for experimental allergic neuritis. J Neuroimmunol 1988;19:167-73.
34. Linington C, Lassmann H, Ozawa K, Kosin S, Mongan L. Cell adhesion molecules of the immunoglobulin supergene family as tissue-specific autoantigens: induction of experimental allergic neuritis (EAN) by P0 protein-specific T cell lines. Eur J Immunol 1992;22:1813-7.
35. Czerkinsky CC, Tarkowski A, Nilsson LA, Ouchterlony O, Nygren H, Gretzer C. Reverse enzyme-linked immunospot assay (RELISPOT) for the detection of cells secreting immunoreactive substances. J Immunol Methods 1984;72: 489-96.
36. Bakhiet M, Özenci V, Withagen C, Mustafa M, Fredrikson S, Link H. A new cell enzyme-linked immunosorbent assay demonstrates gamma interferon suppression by beta interferon in multiple sclerosis. Clin Diagn Lab Immunol 1999;6:415-9.
37. Ossege LM, Sindern E, Voss B, Malin JP. Expression of TNFalpha and TGFbeta1 in Guillain-Barre syndrome: correlation of a low TNFa1-pha-/TGFbeta1- mRNA ratio with good recovery and signs for immunoregulation within the cerebrospinal fluid compartment. Eur J Neurol 2000;7:17-25.
38. Créange A, Belec L, Clair B, Degos JD, Raphaël JC, Gherardi RK. Circulating transforming growth factor beta 1 (TGF-beta1) in Guillain-Barre syndrome: decreased concentrations in the early course and increase with motor function. J Neurol Neurosurg Psychiatry 1998;64:162-5.
39. Hinks GL, Franklin RJ. Distinctive patterns of PDGF-A, FGF-2, IGF-I, and TGF-beta1 gene expression during remyelination of experimentally-induced spinal cord demyelination. Mol Cell Neurosci 1999;14:153-68.
40. John GR, Shankar SL, Shafit-Zagardo B, Massimi A, Lee SC, Raine CS, et al. Multiple sclerosis: re-expression of a developmental pathway that restricts oligodendrocyte maturation. Nat Med 2002;8:1115-21.
41. Gillen C, Jander S, Stoll G. Sequential expression of mRNA for proinflammatory cytokines and interleukin-10 in the rat peripheral nervous system: comparison between immune-mediated demyelination and Wallerian degeneration. J Neurosci Res 1998;51:489-96.
42. Elkarim RA, Dahle C, Mustafa M, Press R, Zou LP, Ekerfelt C, et al. Recovery from Guillain-Barre syndrome is associated with increased levels of neutralizing autoantibodies to interferon-gamma. Clin Immunol Immunopathol 1998;88:241-8.
43. Jander S, Stoll G. Interleukin-18 is induced in acute inflammatory demyelinating polyneuropathy. J Neuroimmunol 2001;114:253-8.
44. Sharief MK, Ingram DA, Swash M. Circulating tumor necrosis factor-alpha correlates with electrodiagnostic abnormalities in Guillain-Barre syndrome. Ann Neurol 1997;42:68-73.
45. Créange A, Belec L, Clair B, Raphaël JC, Gherardi RK. Circulating tumor necrosis factor (TNF)-alpha and soluble TNF-alpha receptors in patients with Guillain-Barre syndrome. J Neuroimmunol 1996;68:95-9.
46. Press R, Özenci V, Kouwenhoven M, Link H. Non-T(H)1 cytokines are augmented systematically early in Guillain-Barre syndrome. Neurology 2002;58:476-8.
47. Ekerfelt C, Ernerudh J, Jenmalm MC. Detection of spontaneous and antigen-induced human interleukin-4 responses in vitro: comparison of ELISPOT, a novel ELISA and real-time RT-PCR. J Immunol Methods 2002;260:55-67.
48. Ekerfelt C, Matthiesen L, Berg G, Ernerudh J. Paternal leukocytes selectively increase secretion of IL-4 in peripheral blood during normal pregnancies: demonstrated by a novel one-way MLC measuring cytokine secretion. Am J Reprod Immunol 1997;38:320-6.
49. Ekerfelt C, Ernerudh J, Vrethem M. Th1-like responses to peptides from peripheral nerve myelin proteins in patients with polyneuropathy associated with monoclonal gammopathy. Clin Exp Immunol 1997;108:516-22.
50. Ekerfelt C, Ernerudh J, Bunikis J, Vrethem M, Aagesen J, Roberg M, et al. Compartmentalization of antigen specific cytokine responses to the central nervous system in CNS borreliosis: secretion of IFN-gamma predominates over IL-4 secretion in response to outer surface proteins of Lyme disease Borrelia spirochetes. J Neuroimmunol 1997;79:155-62.
51. Ekerfelt C, Ernerudh J, Forsberg P, Bergström S. Augmented intrathecal secretion of interferon-gamma in response to Borrelia garinii in neuro-borreliosis. J Neuroimmunol 1998;89:177-81.